| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BBAPAP.2005.07.028 |
| P698 | PubMed publication ID | 16198161 |
| P2093 | author name string | Henrik Daub | |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 183-190 | |
| P577 | publication date | 2005-09-12 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Characterisation of kinase-selective inhibitors by chemical proteomics | |
| P478 | volume | 1754 |
| Q28534337 | A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL |
| Q37234005 | Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. |
| Q42624045 | Computational design of targeted inhibitors of polo-like kinase 1 (plk1). |
| Q46584601 | Design, synthesis and characterization of "clickable" 4-anilinoquinazoline kinase inhibitors |
| Q58231213 | Getting a chemical handle on proteinpost-translational modification |
| Q42013412 | Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics |
| Q47305675 | Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography |
| Q46079038 | In silico profiling of tyrosine kinases binding specificity and drug resistance using Monte Carlo simulations with the ensembles of protein kinase crystal structures. |
| Q37258113 | Large-scale proteomics analysis of the human kinome |
| Q30417855 | Mass spectrometry approaches to monitor protein-drug interactions |
| Q34373301 | Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling. |
| Q36863059 | Pathway proteomics and chemical proteomics team up in drug discovery. |
| Q28280900 | Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry |
| Q54721073 | Proteomics strategy for quantitative protein interaction profiling in cell extracts. |
| Q36553135 | Proteomics technology in systems biology. |
| Q37537095 | Recent advances in chemical proteomics: exploring the post-translational proteome |
| Q34768779 | Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib |
| Q35925610 | The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib |
Search more.